Lv0
0 积分 2023-07-09 加入
Distinct mechanisms underlying therapeutic potentials of CD20 in neurological and neuromuscular disease
6个月前
已完结
Subsequent Secondary CAR-T Cell Therapy Was Superior to Chemotherapy in Patients with Refractory/Relapsed B-Cell Lymphoma after Failure of Anti-CD19 CAR-T Cell Therapy
6个月前
已完结
Two-Year Follow-up Results of C-CAR066, a Novel Anti-CD20 Chimeric Antigen Receptor Cell Therapy (CAR-T) in Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL) Patients after Failure of CD19 CAR-T Therapy
6个月前
已完结
Rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisolone in patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: a phase 3 comparison of dose intensification with 14-day versus 21-day cycles
6个月前
已完结
CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group
6个月前
已完结
Sequential CD19-22 CAR T therapy induces sustained remission in children with r/r B-ALL
7个月前
已完结
SmartPlug Versus Silicone Punctal Plug Therapy for Dry Eye
7个月前
已完结
A phase I, pharmacokinetic and pharmacodynamic study of GSK2256098, a focal adhesion kinase inhibitor, in patients with advanced solid tumors
7个月前
已完结
A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumors
7个月前
已完结
皖公网安备34019202002308
